I hadn’t forgotten adv. Pharma.
But my post was about acquisitions. Advance isn’t big innovative Pharma, who’d heard of them before the announcement, answer honestly.
Look at their website and recent deals. They focus on bringing in generics, biosimilar, heritage and otherwise low tech established stuff like antibiotics and hormones., maybe that’s why they like the repurposed dimx generic. They appear to be more a good sales function house with limited or no internal R&D innovation as such. Apart from the initial down payment, how much are they contributing to rest of trial?
nothing wrong with their business model at all I should add.
- Forums
- ASX - By Stock
- DXB
- Ann: Notification of upcoming expiry of Unlisted Options
Ann: Notification of upcoming expiry of Unlisted Options, page-56
- There are more pages in this discussion • 38 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
62.0¢ |
Change
0.005(0.81%) |
Mkt cap ! $346.3M |
Open | High | Low | Value | Volume |
62.0¢ | 65.0¢ | 61.0¢ | $1.137M | 1.799M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 84816 | 62.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
62.5¢ | 44936 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 29405 | 0.615 |
12 | 140448 | 0.610 |
12 | 263233 | 0.605 |
14 | 390594 | 0.600 |
5 | 845147 | 0.595 |
Price($) | Vol. | No. |
---|---|---|
0.620 | 21850 | 2 |
0.625 | 61649 | 5 |
0.630 | 43838 | 4 |
0.635 | 78001 | 5 |
0.640 | 56561 | 3 |
Last trade - 12.23pm 18/06/2024 (20 minute delay) ? |
|
|||||
Last
62.0¢ |
  |
Change
0.005 ( 0.32 %) |
|||
Open | High | Low | Volume | ||
63.0¢ | 65.0¢ | 61.0¢ | 937189 | ||
Last updated 12.39pm 18/06/2024 ? |
Featured News
DXB (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online